Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Exp Eye Res ; 215: 108908, 2022 02.
Article in English | MEDLINE | ID: mdl-34954204

ABSTRACT

Opticin is an extracellular glycoprotein present in the vitreous. Its antiangiogenic properties offer the potential for therapeutic intervention in conditions such as proliferative diabetic retinopathy and retinopathy of prematurity. Here, we investigated the hypothesis that intravitreal administration of recombinant human opticin can safely protect against the development of pathological angiogenesis and promote its regression. We generated and purified recombinant human opticin and investigated its impact on the development and regression of pathological retinal neovascularization following intravitreal administration in murine oxygen-induced retinopathy. We also investigated its effect on normal retinal vascular development and function, following intravitreal injection in neonatal mice, by histological examination and electroretinography. In oxygen-induced retinopathy, intravitreal administration of human recombinant opticin protected against the development of retinal neovascularization to similar extent as aflibercept, which targets VEGF. Opticin also accelerated regression of established retinal neovascularization, though the effect at 18 h was less than that of aflibercept. Intravitreal administration of human recombinant opticin in neonatal mice caused no detectable perturbation of subsequent retinal vascular development or function. In summary we found that intraocular administration of recombinant human opticin protects against the development of pathological angiogenesis in mice and promotes its regression.


Subject(s)
Hyperoxia , Retinal Neovascularization , Retinopathy of Prematurity , Animals , Disease Models, Animal , Humans , Hyperoxia/complications , Infant, Newborn , Intravitreal Injections , Mice , Mice, Inbred C57BL , Neovascularization, Pathologic , Oxygen/toxicity , Retinal Neovascularization/drug therapy , Retinopathy of Prematurity/drug therapy , Retinopathy of Prematurity/prevention & control
2.
Cell Rep ; 36(5): 109461, 2021 08 03.
Article in English | MEDLINE | ID: mdl-34348137

ABSTRACT

In development, almost all stratified neurons must migrate from their birthplace to the appropriate neural layer. Photoreceptors reside in the most apical layer of the retina, near their place of birth. Whether photoreceptors require migratory events for fine-positioning and/or retention within this layer is not well understood. Here, we show that photoreceptor nuclei of the developing mouse retina cyclically exhibit rapid, dynein-1-dependent translocation toward the apical surface, before moving more slowly in the basal direction, likely due to passive displacement by neighboring retinal nuclei. Attenuating dynein 1 function in rod photoreceptors results in their ectopic basal displacement into the outer plexiform layer and inner nuclear layer. Synapse formation is also compromised in these displaced cells. We propose that repeated, apically directed nuclear translocation events are necessary to ensure retention of post-mitotic photoreceptors within the emerging outer nuclear layer during retinogenesis, which is critical for correct neuronal lamination.


Subject(s)
Cell Nucleus/metabolism , Photoreceptor Cells, Vertebrate/metabolism , Retina/metabolism , Actomyosin/metabolism , Animals , Dyneins/metabolism , Kinetics , Mice, Transgenic , Microtubules/metabolism , Myosin Type II/metabolism , Neurogenesis , Polymerization , Protein Transport , Retinal Cone Photoreceptor Cells/metabolism , Retinal Rod Photoreceptor Cells/metabolism , Synapses/metabolism
3.
Development ; 145(8)2018 04 25.
Article in English | MEDLINE | ID: mdl-29615467

ABSTRACT

In the adult central nervous system, endothelial and neuronal cells engage in tight cross-talk as key components of the so-called neurovascular unit. Impairment of this important relationship adversely affects tissue homeostasis, as observed in neurodegenerative conditions including Alzheimer's and Parkinson's disease. In development, the influence of neuroprogenitor cells on angiogenesis is poorly understood. Here, we show in mouse that these cells interact intimately with the growing retinal vascular network, and we identify a novel regulatory mechanism of vasculature development mediated by hypoxia-inducible factor 2a (Hif2a). By Cre-lox gene excision, we show that Hif2a in retinal neuroprogenitor cells upregulates the expression of the pro-angiogenic mediators vascular endothelial growth factor and erythropoietin, whereas it locally downregulates the angiogenesis inhibitor endostatin. Importantly, absence of Hif2a in retinal neuroprogenitor cells causes a marked reduction of proliferating endothelial cells at the angiogenic front. This results in delayed retinal vascular development, fewer major retinal vessels and reduced density of the peripheral deep retinal vascular plexus. Our findings demonstrate that retinal neuroprogenitor cells are a crucial component of the developing neurovascular unit.


Subject(s)
Basic Helix-Loop-Helix Transcription Factors/metabolism , Neural Stem Cells/cytology , Neural Stem Cells/metabolism , Retinal Vessels/growth & development , Retinal Vessels/innervation , Animals , Astrocytes/cytology , Astrocytes/metabolism , Basic Helix-Loop-Helix Transcription Factors/deficiency , Basic Helix-Loop-Helix Transcription Factors/genetics , Cell Proliferation , Endostatins/metabolism , Gene Expression Regulation, Developmental , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Neovascularization, Physiologic/genetics , Retinal Ganglion Cells/cytology , Retinal Ganglion Cells/metabolism , Retinal Pigment Epithelium/growth & development , Retinal Pigment Epithelium/metabolism , Retinal Vessels/metabolism , Signal Transduction , Vascular Endothelial Growth Factor A/metabolism , Vascular Endothelial Growth Factor Receptor-2/metabolism
4.
Stem Cell Reports ; 8(6): 1659-1674, 2017 06 06.
Article in English | MEDLINE | ID: mdl-28552606

ABSTRACT

The loss of cone photoreceptors that mediate daylight vision represents a leading cause of blindness, for which cell replacement by transplantation offers a promising treatment strategy. Here, we characterize cone differentiation in retinas derived from mouse embryonic stem cells (mESCs). Similar to in vivo development, a temporal pattern of progenitor marker expression is followed by the differentiation of early thyroid hormone receptor ß2-positive precursors and, subsequently, photoreceptors exhibiting cone-specific phototransduction-related proteins. We establish that stage-specific inhibition of the Notch pathway increases cone cell differentiation, while retinoic acid signaling regulates cone maturation, comparable with their actions in vivo. MESC-derived cones can be isolated in large numbers and transplanted into adult mouse eyes, showing capacity to survive and mature in the subretinal space of Aipl1-/- mice, a model of end-stage retinal degeneration. Together, this work identifies a robust, renewable cell source for cone replacement by purified cell suspension transplantation.


Subject(s)
Mouse Embryonic Stem Cells/transplantation , Retinal Cone Photoreceptor Cells/cytology , Retinal Degeneration/therapy , Adaptor Proteins, Signal Transducing/deficiency , Adaptor Proteins, Signal Transducing/genetics , Animals , Basic-Leucine Zipper Transcription Factors/antagonists & inhibitors , Basic-Leucine Zipper Transcription Factors/genetics , Basic-Leucine Zipper Transcription Factors/metabolism , Cell Differentiation/drug effects , Disease Models, Animal , Eye Proteins/antagonists & inhibitors , Eye Proteins/genetics , Eye Proteins/metabolism , Hepatocyte Nuclear Factor 6/metabolism , Leukemia Inhibitory Factor/pharmacology , Mice , Mice, Knockout , Mouse Embryonic Stem Cells/cytology , Oligodendrocyte Transcription Factor 2/metabolism , Opsins/metabolism , Orphan Nuclear Receptors/antagonists & inhibitors , Orphan Nuclear Receptors/genetics , Orphan Nuclear Receptors/metabolism , Otx Transcription Factors/metabolism , RNA Interference , RNA, Small Interfering/metabolism , Receptors, Notch/antagonists & inhibitors , Receptors, Notch/metabolism , Retinal Cone Photoreceptor Cells/metabolism , Retinal Degeneration/pathology , Signal Transduction , Tretinoin/metabolism , Tretinoin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...